ORGANIZATION
Japan Needs New Forum for Top-Level Dialogue Including Global CEOs: PhRMA Chair
Ramona Sequeira, the chair of the Pharmaceutical Research and Manufacturers of America (PhRMA), on October 27 called for setting up a new forum that brings together top Japanese government officials and CEOs of global pharma companies to reverse the course…
To read the full story
Related Article
- Takeda’s Ramona Sequeira Becomes 1st Female PhRMA Chair
February 15, 2022
ORGANIZATION
- APAC Disbands Drug Discovery WG as Asia Capabilities Rise
April 23, 2026
- Flight Cuts, Fuel Costs Tied to Iran Crisis Threaten API Imports: Trader
April 23, 2026
- JPMA to Set Up Task Force on US MFN Policy, First Meeting Seen This Month
April 21, 2026
- PhRMA Warns Japan Launches Could Erode Global Revenues amid US MFN Policy
April 20, 2026
- JPMA Exec Frets over Material Cost Surge amid Middle East Crisis
April 17, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





